Debate on the treatment of multiple sclerosis: Experience from an intractable multiple sclerosis case with rebound syndrome after fingolimod cessation
Sign Up to like & getrecommendations! Published in 2019 at "Clinical and Experimental Neuroimmunology"
DOI: 10.1111/cen3.12504
Abstract: Fingolimod is an effective disease‐modifying drug for relapsing–remitting multiple sclerosis (RRMS), but drug discontinuation might cause rebound syndrome, defined as massive and prolonged exacerbation of MS. We report a case of intractable MS with rebound… read more here.
Keywords: sclerosis; case; fingolimod cessation; syndrome fingolimod ... See more keywords